|
1
|
Reinke JM and Sorg H: Wound repair and
regeneration. Eur Surg Res. 49:35–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Orgill DP and Ogawa R: Current methods of
burn reconstruction. Plast Reconstr Surg. 131:827e–836e. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kagan RJ, Peck MD, Ahrenholz DH, Hickerson
WL, Holmes J IV, Korentager R, Kraatz J, Pollock K and Kotoski G:
Surgical management of the burn wound and use of skin substitutes:
an expert panel white paper. J Burn Care Res. 34:e60–e79. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiu T and Burd A: “Xenograft” dressing in
the treatment of burns”. Clin Dermatol. 23:419–423. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiu T, Pang P, Ying SY and Burd A:
Porcine skin: Friend or foe? Burns. 30:739–741. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng X, Shen R, Tan J, Chen X, Pan Y, Ruan
S, Zhang F, Lin Z, Zeng Y, Wang X, et al: The study of inhibiting
systematic inflammatory response syndrome by applying xenogenic
(porcine) acellular dermal matrix on second-degree burns. Burns.
33:477–479. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng X, Tan J, Pan Y, Wu Q, Ruan S, Shen
R, Chen X and Du Y: Control of hypertrophic scar from inception by
using xenogenic (porcine) acellular dermal matrix (ADM) to cover
deep second degree burn. Burns. 32:293–298. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allman AJ, McPherson TB, Badylak SF,
Merrill LC, Kallakury B, Sheehan C, Raeder RH and Metzger DW:
Xenogeneic extra-cellular matrix grafts elicit a TH2-restricted
immune response. Transplantation. 71:1631–1640. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang D, Chen B, Xu M, Hu D, Tang C and
Zhu X: The manufacturing and clinical application of heterogenous
acellular dermal matrix. Zhonghua Shao Shang Za Zhi. 18:15–18.
2002.In Chinese.
|
|
10
|
Philandrianos C, Andrac-Meyer L, Mordon S,
Feuerstein JM, Sabatier F, Veran J, Magalon G and Casanova D:
Comparison of five dermal substitutes in full-thickness skin wound
healing in a porcine model. Burns. 38:820–829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Truong AT, Kowal-Vern A, Latenser BA,
Wiley DE and Walter RJ: Comparison of dermal substitutes in wound
healing utilizing a nude mouse model. J Burns Wounds. 4:e42005.
|
|
12
|
Chen SG, Tzeng YS and Wang CH: Treatment
of severe burn with DermACELL(®), an acellular dermal matrix. Int J
Burns Trauma. 2:105–109. 2012.
|
|
13
|
Solomon JR: Early surgical excision and
grafting of burns including tangential excision. Prog Pediatr Surg.
14:133–149. 1981.PubMed/NCBI
|
|
14
|
Sparkes BG, Monge G, Marshall SL, Peters
WJ, Allgöwer M and Schoenenberger GA: Plasma levels of cutaneous
burn toxin and lipid peroxides in thermal injury. Burns.
16:118–122. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hiramatsu M, Izawa Y, Hagihara M,
Nishigaki I and Yagi K: Serum lipid peroxide levels of patients
suffering from thermal injury. Burns Incl Therm Inj. 11:111–116.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schoenenberger GA: Burn toxins isolated
from mouse and human skin. Their characterization and immunotherapy
effects. Monogr Allergy. 9:72–139. 1975.PubMed/NCBI
|
|
17
|
Allgöwer M, Cueni LB, Städtler K and
Schoenenberger GA: Burn toxin in mouse skin. J Trauma. 13:95–111.
1973. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Constantian MB: Association of sepsis with
an immunosuppressive polypeptide in the serum of burn patients. Ann
Surg. 188:209–215. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ozkan AN and Ninnemann JL: Circulating
mediators in thermal injuries: Isolation and characterization of a
burn injury-induced immunosuppressive serum component. J Burn Care
Rehabil. 6:147–151. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schoenenberger GA, Burkhardt F, Kalberer
F, Müller W, Städtler K, Vogt P and Allgöwer M: Experimental
evidence for a significant impairment of host defense for
gram-negative organisms by a specific cutaneous toxin produced by
severe burn injuries. Surg Gynecol Obstet. 141:555–561.
1975.PubMed/NCBI
|
|
21
|
Kremer B, Allgöwer M, Scheidegger AM,
Schmidt KH, Schölmerich J, Wüst B and Schoenenberger GA:
Toxin-specific ultra-structural alterations of the mouse liver
after burn injuries and the possibility of a specific antitoxic
therapy. Scand J Plast Reconstr Surg. 13:217–222. 1979. View Article : Google Scholar
|
|
22
|
Schölmerich J, Kremer B, Schmidt K,
Setyadharma H, Richter IE and Schoenenberger GA: Effects of peptide
hormones on urea- and glycogen-synthesis of isolated hepatocytes
and the influence of a toxic factor from burnt mouse and human
skin. Horm Metab Res. 14:80–84. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ninnemann JL and Stein MD: Suppressor cell
induction by povidone-iodine: In vitro demonstration of a
consequence of clinical burn treatment with betadine. J Immunol.
126:1905–1908. 1981.PubMed/NCBI
|
|
24
|
Sparkes BG, Gyorkos JW, Gorczynski RM and
Brock AJ: Comparison of endotoxins and cutaneous burn toxin as
immunosuppressants. Burns. 16:123–127. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sparkes BG: Mechanisms of immune failure
in burn injury. Vaccine. 11:504–510. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang XC, Li C, Shan F, Wang WT, Zhu XG and
Jiang DY: Experimental study on the recycling of denatured
acellular dermal matrix after burn. Zhonghua Shao Shang Za Zhi.
28:201–206. 2012.In Chinese. PubMed/NCBI
|
|
27
|
Lu KH and Li HY: Study on the management
of postburn pathological scars. Zhonghua Shao Shang Za Zhi.
20:65–66. 2004.In Chinese. PubMed/NCBI
|
|
28
|
Eldad A, Din A, Weinberg A, Neuman A,
Lipton H, Ben-Bassat H, Chaouat M and Wexler MR: Cryopreserved
cadaveric allografts for treatment of unexcised partial thickness
flame burns: Clinical experience with 12 patients. Burns.
23:608–614. 1997. View Article : Google Scholar
|
|
29
|
Purdue GF, Hunt JL, Still JM Jr, Law EJ,
Herndon DN, Goldfarb IW, Schiller WR, Hansbrough JF, Hickerson WL,
Himel HN, et al: A multicenter clinical trial of a biosynthetic
skin replacement, Dermagraft-TC, compared with cryopreserved human
cadaver skin for temporary coverage of excised burn wounds. J Burn
Care Rehabil. 18:52–57. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anderson JR, Fear MW, Phillips JK, Dawson
LF, Wallace H, Wood FM and Rea SM: A preliminary investigation of
the reinnervation and return of sensory function in burn patients
treated with INTEGRA®. Burns. 37:1101–1108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu SL, Liao ZJ, Xiang J, Wang ZY, Yang LY
and Shi JX: Clinical observation of the effect of tangential
excision within 24 postburn hours on the patients with deep partial
thickness burn. Zhonghua Shao Shang Za Zhi. 19:326–328. 2003.In
Chinese.
|
|
32
|
Wang ZQ, Cai BR, Xiao J, Hao GH, Wu JB and
Zhao XH: The clinical staging and tissue bacterial quantification
in the diagnosis of burn wound sepsis. Zhonghua Shao Shang Za Zhi.
19:282–284. 2003.In Chinese. PubMed/NCBI
|
|
33
|
Zhang Z, Lv L, Mamat M, Chen Z, Liu L and
Wang Z: Xenogenic (porcine) acellular dermal matrix is useful for
the wound healing of severely damaged extremities. Exp Ther Med.
7:621–624. 2014.PubMed/NCBI
|
|
34
|
Lavine M, Frisk M and Pennisi E:
Biomaterials. Introduction. Science. 338:8992012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mehrali M, Shirazi FS, Mehrali M,
Metselaar HS, Kadri NA and Osman NA: Dental implants from
functionally graded materials. J Biomed Mater Res A. 101:3046–3057.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leong KF, Chua CK, Sudarmadji N and Yeong
WY: Engineering functionally graded tissue engineering scaffolds. J
Mech Behav Biomed Mater. 1:140–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen X, Shi Y, Shu B, Xie X, Yang R, Zhang
L, Ruan S, Lin Y, Lin Z, Shen R, et al: The effect of porcine ADM
to improve the burn wound healing. Int J Clin Exp Pathol.
6:2280–2291. 2013.PubMed/NCBI
|
|
38
|
Pierce MC, Sheridan RL, Hyle Park B, Cense
B and de Boer JF: Collagen denaturation can be quantified in burned
human skin using polarization-sensitive optical coherence
tomography. Burns. 30:511–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cuttle L, Kempf M, Phillips GE, Mill J,
Hayes MT, Fraser JF, Wang XQ and Kimble RM: A porcine deep dermal
partial thickness burn model with hypertrophic scarring. Burns.
32:806–820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hayashi K and Markel MD: Thermal
capsulorrhaphy treatment of shoulder instability: Basic science.
Clin Orthop Relat Res. 390:59–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hall BM: Cells mediating allograft
rejection. Transplantation. 51:1141–1151. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Alegre ML, Florquin S and Goldman M:
Cellular mechanisms underlying acute graft rejection: Time for
reassessment. Curr Opin Immunol. 19:563–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
van Minnen B, van Leeuwen MB, Stegenga B,
Zuidema J, Hissink CE, van Kooten TG and Bos RR: Short-term in
vitro and in vivo biocompatibility of a biodegradable polyurethane
foam based on 1,4-butanediisocyanate. J Mater Sci Mater Med.
16:221–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pomahac B, Svensjö T, Yao F, Brown H and
Eriksson E: Tissue engineering of skin. Crit Rev Oral Biol Med.
9:333–344. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Prasad T, Shabeena EA, Vinod D, Kumary TV
and Anil Kumar PR: Characterization and in vitro evaluation of
electrospun chitosan/polycaprolactone blend fibrous mat for skin
tissue engineering. J Mater Sci Mater Med. 26:53522015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mañez R, White LT, Linden P, Kusne S,
Martin M, Kramer D, Demetris AJ, Van Thiel DH, Starzl TE and
Duquesnoy RJ: The influence of HLA matching on cytomegalovirus
hepatitis and chronic rejection after liver transplantation.
Transplantation. 55:1067–1071. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Borschel GH, Dennis RG and Kuzon WM Jr:
Contractile skeletal muscle tissue-engineered on an acellular
scaffold. Plast Reconstr Surg. 113:595–602; discussion 603–604.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Badylak SF: The extracellular matrix as a
biologic scaffold material. Biomaterials. 28:3587–3593. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Low PS, Tjin MS and Fong E: Design and
Construction of Artificial Extracellular Matrix (aECM) Proteins
from Escherichia coli for Skin Tissue Engineering. J Vis Exp.
e528452015.PubMed/NCBI
|
|
50
|
Sundaramurthi D, Krishnan UM and
Sethuraman S: Biocompatibility of
poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanofibers for
skin tissue engineering. J Biomed Nanotechnol. 9:1383–1392. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Müller WE and Müller IM: Origin of the
metazoan immune system: Identification of the molecules and their
functions in sponges. Integr Comp Biol. 43:281–292. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Singer AJ and Clark RA: Cutaneous wound
healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Velnar T, Bailey T and Smrkolj V: The
wound healing process: An overview of the cellular and molecular
mechanisms. J Int Med Res. 37:1528–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chang KC, Ma H, Liao WC, Lee CK, Lin CY
and Chen CC: The optimal time for early burn wound excision to
reduce pro-inflammatory cytokine production in a murine burn injury
model. Burns. 36:1059–1066. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Drost AC, Burleson DG, Cioffi WG Jr, Mason
AD Jr and Pruitt BA Jr: Plasma cytokines after thermal injury and
their relationship to infection. Ann Surg. 218:74–78. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Beutler B and Cerami A: The biology of
cachectin/TNF–a primary mediator of the host response. Annu Rev
Immunol. 7:625–655. 1989. View Article : Google Scholar
|
|
57
|
Tan EM, Hoffren J, Rouda S, Greenbaum S,
Fox JW IV, Moore JH Jr and Dodge GR: Decorin, versican, and
biglycan gene expression by keloid and normal dermal fibroblasts:
differential regulation by basic fibroblast growth factor. Exp Cell
Res. 209:200–207. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Honardoust D, Varkey M, Marcoux Y,
Shankowsky HA and Tredget EE: Reduced decorin, fibromodulin, and
transforming growth factor-β3 in deep dermis leads to hypertrophic
scarring. J Burn Care Res. 33:218–227. 2012. View Article : Google Scholar
|
|
59
|
Ogle CK, Kong F, Guo X, Wells DA, Aosasa
S, Noel G and Horseman N: The effect of burn injury on suppressors
of cytokine signalling. Shock. 14:392–399. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lejeune D, Demoulin JB and Renauld JC:
Interleukin 9 induces expression of three cytokine signal
inhibitors: Cytokine-inducible SH2-containing protein, suppressor
of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3
overexpression suppresses interleukin 9 signalling. Biochem J.
353:109–116. 2001. View Article : Google Scholar
|
|
61
|
Pilette C, Ouadrhiri Y, Van Snick J,
Renauld JC, Staquet P, Vaerman JP and Sibille Y: IL-9 inhibits
oxidative burst and TNF-alpha release in
lipopolysaccharide-stimulated human monocytes through TGF-beta. J
Immunol. 168:4103–4111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Nall AV, Brownlee RE, Colvin CP, Schultz
G, Fein D, Cassisi NJ, Nguyen T and Kalra A: Transforming growth
factor beta 1 improves wound healing and random flap survival in
normal and irradiated rats. Arch Otolaryngol Head Neck Surg.
122:171–177. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Roberts AB, Sporn MB, Assoian RK, Smith
JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V and
Kehrl JH: Transforming growth factor type beta: rapid induction of
fibrosis and angiogenesis in vivo and stimulation of collagen
formation in vitro. Proc Natl Acad Sci USA. 83:4167–4171. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bornstein P, Agah A and Kyriakides TR: The
role of thrombospondins 1 and 2 in the regulation of cell-matrix
interactions, collagen fibril formation, and the response to
injury. Int J Biochem Cell Biol. 36:1115–1125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Streit M, Velasco P, Riccardi L, Spencer
L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T,
Iruela-Arispe L and Detmar M: Thrombospondin-1 suppresses wound
healing and granulation tissue formation in the skin of transgenic
mice. EMBO J. 19:3272–3282. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Isenberg JS, Pappan LK, Romeo MJ, Abu-Asab
M, Tsokos M, Wink DA, Frazier WA and Roberts DD: Blockade of
thrombos-pondin-1-CD47 interactions prevents necrosis of full
thickness skin grafts. Ann Surg. 247:180–190. 2008. View Article : Google Scholar :
|
|
67
|
Emanuele NV, LaPaglia N, Kovacs EJ and
Emanuele MA: The impact of burn injury and ethanol on the cytokine
network of the mouse hypothalamus: Reproductive implications.
Cytokine. 30:109–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
de Bandt JP, Chollet-Martin S, Hernvann A,
Lioret N, du Roure LD, Lim SK, Vaubourdolle M, Guechot J, Saizy R,
Giboudeau J and Cynober L: Cytokine response to burn injury:
Relationship with protein metabolism. J Trauma. 36:624–628. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Drost AC, Burleson DG, Cioffi WG Jr,
Jordan BS, Mason AD Jr and Pruitt BA Jr: Plasma cytokines following
thermal injury and their relationship with patient mortality, burn
size, and time postburn. J Trauma. 35:335–339. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhang Z, Garron TM, Li XJ, Liu Y, Zhang X,
Li YY and Xu WS: Recombinant human decorin inhibits
TGF-beta1-induced contraction of collagen lattice by hypertrophic
scar fibroblasts. Burns. 35:527–537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Chen S, Young MF, Chakravarti S and Birk
DE: Interclass small leucine-rich repeat proteoglycan interactions
regulate collagen fibrillogenesis and corneal stromal assembly.
Matrix Biol. 35:103–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gillard JA, Reed MW, Buttle D, Cross SS
and Brown NJ: Matrix metalloproteinase activity and
immunohistochemical profile of matrix metalloproteinase-2 and -9
and tissue inhibitor of metalloproteinase-1 during human dermal
wound healing. Wound Repair Regen. 12:295–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Serini G, Bochaton-Piallat ML, Ropraz P,
Geinoz A, Borsi L, Zardi L and Gabbiani G: The fibronectin domain
ED-A is crucial for myofibroblastic phenotype induction by
transforming growth factor-beta1. J Cell Biol. 142:873–881. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Smith PC, Cáceres M and Martinez J:
Induction of the myofibroblastic phenotype in human gingival
fibroblasts by transforming growth factor-beta1: Role of RhoA-ROCK
and c-Jun N-terminal kinase signaling pathways. J Periodontal Res.
41:418–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Lu L, Saulis AS, Liu WR, Roy NK, Chao JD,
Ledbetter S and Mustoe TA: The temporal effects of anti-TGF-beta1,
2, and 3 monoclonal antibody on wound healing and hypertrophic scar
formation. J Am Coll Surg. 201:391–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
